2025 Controlled Substances FDA 
The FDA Law Blog
MAY 19, 2025
Attorneys Office, Northern District of Illinois, April 21, 2025. While the presence of a dispensing red flag does not prohibit a pharmacist from filling a controlled substance, it means that there is a potential concern with the prescription, which the pharmacist must address andmake a record of its resolution, assuming it is resolvable.
pharmaphorum
DECEMBER 14, 2022
Sodium oxybate — which in the late 1980s was marketed to bodybuilders and then became known as GHB and criminally used as a date rape drug — has been sold under the brand name Xyrem after gaining FDA approval in 2002. In 2020, the FDA-approved indication was expanded to include those patients who suffer from cataplexy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The FDA Law Blog
FEBRUARY 18, 2025
23, 2025), DEA reviewed evidence from an administrative hearing and upheld the Administrative Law Judges (ALJs) recommended decision to revoke the registration of a pharmacy that DEA alleged dispensed controlled substances to patients without resolving numerous red flags of diversion. In Neumanns Pharmacy, LLC , 90 Fed.
The FDA Law Blog
JUNE 3, 2025
Attorneys Office, Northern District of Illinois, April 21, 2025, quoted here. Press Release, Walgreens Agrees To Pay Up to $350M for Illegally Filling Unlawful Opioid Prescriptions and Submitting False Claims, U.S.
The FDA Law Blog
DECEMBER 12, 2024
The NPRM seeks to reschedule marijuana from schedule I of the federal Controlled Substances Act (CSA) to schedule III. Last weeks prehearing conference set the parameters for the hearing on the merits, scheduled to begin January 21, 2025. Prehearing Ruling (Dec. 4, 2024), at 1.
Drug Topics
JUNE 10, 2025
Kreckel, RPh Publication Article Drug Topics Journal Drug Topics May/June 2025 Volume 169 Issue 03 Our whole country needs to do better in providing harm reduction services, including naloxone and syringe service programs. Under Pennsylvania law, possession of drug paraphernalia is prohibited.
The FDA Law Blog
FEBRUARY 11, 2025
Houck One of the most significant issues facing hospitals and other facilities is the diversion of controlled substances meant for patients by physicians, pharmacists, nurses and other trusted healthcare employees.
Expert insights. Personalized for you.
64 
Let's personalize your content